Biocompatible HA-PBA/PVA Dual-Network Hydrogel Composite System: A Promising Localized Therapeutic Platform for Bladder Cancer.
Bladder cancer is among the most common malignancies of the urinary system and is characterized by high recurrence rates and unsatisfactory clinical outcomes. Current therapeutic strategies are limited by inadequate local efficacy, rapid drug loss caused by the bladder microenvironment, and systemic toxicity associated...